GOTHENBURG – November 04, 2026 -- Zinzino's group revenue rose 1% in October to SEK 328.7 million, up from SEK 326.0 million a year earlier, as growth slowed sharply against the year-to-date pace.
Sales markets add 1% to reach SEK 325.1 million
Revenue from Zinzino's sales markets increased to SEK 325.1 million in October, compared with SEK 323.3 million in the prior-year month. The increase of SEK 1.8 million accounts for most of the group's monthly gain.
Faun Pharma external sales climb 33% to SEK 3.6 million
Faun Pharma's external sales rose to SEK 3.6 million from SEK 2.7 million. The unit remains small, contributing about 1% of group revenue for the month.
January-October revenue grows 19% to SEK 3,128.0 million
Accumulated revenue for the first ten months of 2026 reached SEK 3,128.0 million, against SEK 2,628.2 million in the same period of 2025. That is an increase of roughly SEK 499.8 million. October's 1% growth sits well below the 19% year-to-date rate.
Reporting spans nine regions from the Nordics to Africa
Zinzino reports revenue across nine regions: the Nordics, Central Europe, East Europe, South & West Europe, the Baltics, North America, South America, Asia-Pacific and Africa. North America covers Canada, the USA and Mexico. South America comprises Peru and Colombia, and Africa is represented by South Africa. The release does not break out revenue by region.